These final results, together with a earlier report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 assist the idea of targeting ACKR3 as a novel method to modulate the opioid technique, which could open up new therapeutic avenues for opioid-related Problems. By ticking this box https://emmab405evl1.blogacep.com/profile